These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22482337)

  • 1. Importance of certain pro-inflammatory indices in patients with liver cirrhosis and bacterial infection on prognosis and course of the disease.
    Dinic-Radovic V; Nagorni A; Brzacki V; Ristic L; Radovic M
    Med Arh; 2012; 66(1):19-23. PubMed ID: 22482337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.
    Kwon JH; Jang JW; Kim YW; Lee SW; Nam SW; Jaegal D; Lee S; Bae SH
    BMC Gastroenterol; 2015 Oct; 15():146. PubMed ID: 26498833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarifying the role of C-reactive protein as a bacterial infection predictor in decompensated cirrhosis.
    Perdigoto DN; Figueiredo PN; Tomé LF
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):645-651. PubMed ID: 29384797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis.
    Lazzarotto C; Ronsoni MF; Fayad L; Nogueira CL; Bazzo ML; Narciso-Schiavon JL; de Lucca Schiavon L; Dantas-Corrêa EB
    Ann Hepatol; 2013; 12(4):599-607. PubMed ID: 23813138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
    Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
    World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection.
    Abdel-Razik A; Eldars W; Rizk E
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1342-7. PubMed ID: 25222550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating endocan in patients with cirrhosis: relation to bacterial infection and severity of disease.
    Zuwala-Jagiello J; Simon K; Kukla M; Murawska-Cialowicz E; Gorka-Dynysiewicz J; Grzebyk E; Pazgan-Simon M
    J Physiol Pharmacol; 2017 Apr; 68(2):273-282. PubMed ID: 28614777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis.
    Le Moine O; Devière J; Devaster JM; Crusiaux A; Durand F; Bernuau J; Goldman M; Benhamou JP
    J Hepatol; 1994 Jun; 20(6):819-24. PubMed ID: 7930484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of procalcitonin in patients with cirrhosis hospitalized for acute infection.
    Girardi P; Buono R; Bisazza C; Marchi L; Angeli P; Di Pascoli M
    Dig Liver Dis; 2024 May; 56(5):810-817. PubMed ID: 37845154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.
    Lopes-Secundo TM; Sevá-Pereira T; Correa BR; Silva NCM; Imbrizi MR; Cunha-Silva M; Soares EC; Almeida JRS
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1055-1059. PubMed ID: 29944488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of serum C-reactive protein measurement in the detection of bacterial infection in patients with liver cirrhosis.
    Lin ZY; Chuang WL; Dai CY; Yu ML; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY
    Kaohsiung J Med Sci; 2002 Mar; 18(3):121-6. PubMed ID: 12149826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
    Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC
    J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease.
    Elefsiniotis IS; Skounakis M; Vezali E; Pantazis KD; Petrocheilou A; Pirounaki M; Papatsibas G; Kontou-Kastellanou C; Moulakakis A
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):525-30. PubMed ID: 16607149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.
    Chirapongsathorn S; Bunraksa W; Chaiprasert A; Punpanich D; Supasyndh O; Kamath PS
    J Gastroenterol Hepatol; 2018 Mar; 33(3):726-732. PubMed ID: 28840619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis.
    Lin KH; Wang FL; Wu MS; Jiang BY; Kao WL; Chao HY; Wu JY; Lee CC
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):72-8. PubMed ID: 24974271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.
    Vogt A; Reuken PA; Stengel S; Stallmach A; Bruns T
    World J Gastroenterol; 2016 Mar; 22(11):3275-84. PubMed ID: 27004006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
    Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections.
    Piano S; Morando F; Carretta G; Tonon M; Vettore E; Rosi S; Stanco M; Pilutti C; Romano A; Brocca A; Sticca A; Donato D; Angeli P
    Am J Gastroenterol; 2017 Oct; 112(10):1575-1583. PubMed ID: 28853729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.